JAKARTA/HANOI -- Vaccine diplomacy by China and the U.S. has entered a new stage as their drugmakers transfer technology to players in Southeast Asia to kick-start local production.
Drugmakers test new COVID-19 shots in region with eye on local production
A healthcare worker in Jakarta holds up a vial of the Sinopharm vaccine. Chinese and U.S. companies are conducting clinical trials for new alternatives in Indonesia. © Reuters
JAKARTA/HANOI -- Vaccine diplomacy by China and the U.S. has entered a new stage as their drugmakers transfer technology to players in Southeast Asia to kick-start local production.